Symposium:
209. Clinical Conundrums in UTI Management: From Diagnosis to Antimicrobial Resistance
Saturday, October 29, 2016: 10:30 AM-12:00 PM
Room: 393-396

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • distinguish how asymptomatic bacteriuria differs from urinary tract infection
  • identify the major causes of antimicrobial resistant urinary tract infection in the outpatient setting
  • define duration of therapy for multiple types of common urinary tract infections

Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Hospital epidemiologists, Infection preventionists, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Members-in-training, Microbiologists, Nurses, Researchers, Scientists

Tracks: Pediatric ID, Investigative ID, Epidemiology and Infection Control, Adult ID

Moderators:  Samuel Shelburne, MD, PhD, FIDSA, The University of Texas MD Anderson Cancer Center and Barbara W. Trautner, MD, PhD, FIDSA, Baylor College of Medicine

Presentations:
10:30 AM
1760
Distinguishing Asymptomatic Bacteriuria from True Urinary Tract Infection: A Cornerstone of Antimicrobial Stewardship
Barbara W. Trautner, MD, PhD, FIDSA

10:55 AM
Q&A
11:00 AM
1761
How to Approach the Management of Outpatient Urinary Tract Infections in an Era of Escalating Antimicrobial Resistance
Ann Stapleton, MD
11:25 AM
Q&A
11:30 AM
1762
Duration of Therapy for Urinary Tract Infections: How Low Can We Go?
Dimitri M. Drekonja, MD, MS, FIDSA

11:55 AM
Q&A

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.5 knowledge-based contact hours 0.15 of pharmacy CE

ACPE Number: 0221-9999-16-289-L01-P

Disclosures:

S. Shelburne, None

B. W. Trautner, Zambon Pharmaceuticals: Consultant , Consulting fee

See more of: Symposium
<< Previous Session | Next Session >>

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.